Stay updated on SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page.
Latest updates to the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this aspect.SummaryDifference0.1%
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check42 days agoChange DetectedThe website now displays contact information for studies open to participants, expanding visibility beyond just those recruiting subjects.SummaryDifference0.1%
- Check56 days agoChange DetectedThe website has removed a detailed section regarding data download options and fields related to clinical study information.SummaryDifference0.9%
- Check63 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options in various file formats and enhanced data field selection for studies.SummaryDifference0.9%
- Check78 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.0%
Stay in the know with updates to SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page.